Search Results - David J. Lederer
- Showing 1 - 20 results of 88
- Go to Next Page
-
1
Selecting lung transplant candidates: where do current guidelines fall short? by J.L. Hook, David J. Lederer
Published 2012Revisão -
2
Micromechanics of Alveolar Edema by Carrie E. Perlman, David J. Lederer, Jahar Bhattacharya
Published 2010Artigo -
3
-
4
Frailty in Pulmonary and Critical Care Medicine by Jonathan P. Singer, David J. Lederer, Matthew R. Baldwin
Published 2016Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial by Toby M. Maher, Tamera J. Corte, Aryeh Fischer, Michael Kreuter, David J. Lederer, María Molina‐Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Vincent Cottin
Published 2018Artigo -
15
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis by Michael Kreuter, David J. Lederer, María Molina‐Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin
Published 2019Artigo -
16
-
17
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function by Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan, Marilyn K. Glassberg, Eduard Gorina, Lisa Lancaster, David J. Lederer, Steven D. Nathan, Dominique Spirig, Jeff Swigris
Published 2016Artigo -
18
Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation by David J. Lederer, Jessie S. Wilt, F. D’Ovidio, Matthew Bacchetta, Lori Shah, Shankari Ravichandran, J. -L. J. Lenoir, Brenda Klein, Joshua Sonett, Selim M. Arcasoy
Published 2009Artigo -
19
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and... by Toby M. Maher, Michael Kreuter, David J. Lederer, Kevin K. Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi‐Saab, Marlies Wijsenbeek
Published 2019Artigo -
20
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis by Steven D. Nathan, Ulrich Costabel, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Carlos A.C. Pereira, Benjamin Trzaskoma, Elizabeth Morgenthien, Susan L. Limb, Athol U. Wells
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Lung
Pathology
Lung transplantation
Transplantation
Idiopathic pulmonary fibrosis
Confidence interval
Surgery
Gastroenterology
Alternative medicine
Intensive care medicine
Placebo
Cardiology
Biology
Hazard ratio
Interstitial lung disease
Environmental health
Population
Asthma
Cohort
Immunology
Gene
Genetics
Pediatrics
Prospective cohort study
Body mass index
Clinical trial
Lung function
Odds ratio